Advanced search
Publication Cover
Leukemia & Lymphoma Volume 58, 2017 - Issue 8
Submit an article Journal homepage
732
Views
11
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Outcomes for transformed follicular lymphoma in the rituximab era: the Royal Marsden experience 2003–2013

Mary GleesonThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Eliza A. HawkesDepartment of Oncology and Clinical Haematology, Austin Health, Heidelberg, Melbourne, Australia; ;Eastern Health, Melbourne, Australia
,
Clare PeckittThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Andrew WotherspoonThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Ayoma AttygalleThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Bhupinder SharmaThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Yong DuThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Mark EthellThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Mike PotterThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Claire DeardenThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Alan HorwichThe Royal Marsden Hospital, London and Surrey, United Kingdom;
,
Ian ChauThe Royal Marsden Hospital, London and Surrey, United Kingdom;
&
David CunninghamThe Royal Marsden Hospital, London and Surrey, United Kingdom; Correspondence[email protected]
 show all
Pages 1805-1813 | Received 18 Jul 2016, Accepted 21 Nov 2016, Published online: 08 Dec 2016

Citations (11)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

Adrian Minson & Michael Dickinson. (2021) Too much, or not enough? The enduring uncertainty of maintenance rituximab for transformed follicular lymphoma. Leukemia & Lymphoma 62:9, pages 2047-2049.
Read now
Collin K. Chin, Maria A. Rodriguez, Yun Qing, Lei Feng, Felipe Samaniego, Preetesh Jain, Mansoor Noorani, Nathan H. Fowler, Luis E. Fayad, Jason R. Westin, Sattva S. Neelapu, Frederick B. Hagemeister, Christopher R. Flowers & Loretta J. Nastoupil. (2020) Impact of maintenance rituximab in patients with de novo transformed indolent B cell lymphoma. Leukemia & Lymphoma 61:12, pages 2985-2989.
Read now
Paolo Strati, Mohamed Amin Ahmed, Loretta J. Nastoupil, Lei Feng, Fredrick B. Hagemeister, Luis E. Fayad, Maria A. Rodriguez, Felipe Samaniego, Michael Wang, Jason R. Westin, Hun J. Lee, Swaminathan P. Iyer, Simrit Parmar, Sairah Ahmed, Ranjit Nair, Raphael E. Steiner, Mansoor Noorani, Christopher R. Flowers, R. Eric Davis, Nathan H. Fowler & Sattva S. Neelapu. (2020) Pretreatment SUVmax may influence the clinical benefit of BR over R-CHOP in patients with previously untreated FL. Leukemia & Lymphoma 61:6, pages 1380-1387.
Read now

Articles from other publishers (8)

Eric Jacobsen. (2022) Follicular lymphoma: 2023 update on diagnosis and management. American Journal of Hematology 97:12, pages 1638-1651.
Crossref
Michael Northend & William Townsend. (2021) Novel Therapy Approaches to Follicular Lymphoma. Drugs 81:4, pages 453-469.
Crossref
Sonali Smith. (2020) Transformed lymphoma: what should I do now?. Hematology 2020:1, pages 306-311.
Crossref
Arnold Freedman & Eric Jacobsen. (2019) Follicular lymphoma: 2020 update on diagnosis and management. American Journal of Hematology 95:3, pages 316-327.
Crossref
Andrew D. ZelenetzLeo I. GordonJeremy S. AbramsonRanjana H. AdvaniNancy L. BartlettPaolo F. CaimiJulie E. ChangJulio C. ChavezBeth ChristianLuis E. FayadMartha J. GlennThomas M. HabermannNancy Lee HarrisFrancisco Hernandez-IlizaliturriMark S. KaminskiChristopher R. KelseyNadia KhanSusan KrivacicAnn S. LaCasceAmitkumar MehtaAuayporn NademaneeRachel RabinovitchNishitha ReddyErin ReidKenneth B. RobertsStephen D. SmithErin D. SnyderLode J. SwinnenJulie M. Vose, Mary A. DwyerHema Sundar. (2019) NCCN Guidelines Insights: B-Cell Lymphomas, Version 3.2019. Journal of the National Comprehensive Cancer Network 17:6, pages 650-661.
Crossref
James Godfrey, Michael J. Leukam & Sonali M. Smith. (2018) An update in treating transformed lymphoma. Best Practice & Research Clinical Haematology 31:3, pages 251-261.
Crossref
Brian K. Link. (2018) Transformation of follicular lymphoma – Why does it happen and can it be prevented?. Best Practice & Research Clinical Haematology 31:1, pages 49-56.
Crossref
Thais Fischer, Natalia Pin Chuen Zing, Carlos Sergio Chiattone, Massimo Federico & Stefano Luminari. (2017) Transformed follicular lymphoma. Annals of Hematology 97:1, pages 17-29.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.